Clinical Trial Update: WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the WT1 vaccine in patients in remission from acute myeloid leukemia or acute lymphoblastic leukemia has completed enrollment and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• WT1 Vaccine (WT1 peptide vaccine)

Snippet

Sponsor: Sellas Life Sciences Group | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2024-11-19